These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28168996)

  • 1. Ribosome biogenesis and cancer.
    Derenzini M; Montanaro L; Trerè D
    Acta Histochem; 2017 Apr; 119(3):190-197. PubMed ID: 28168996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosome biogenesis and control of cell proliferation: p53 is not alone.
    Donati G; Montanaro L; Derenzini M
    Cancer Res; 2012 Apr; 72(7):1602-7. PubMed ID: 22282659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
    Brighenti E; Treré D; Derenzini M
    Oncotarget; 2015 Nov; 6(36):38617-27. PubMed ID: 26415219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ribosome Biogenesis-Cancer Connection.
    Penzo M; Montanaro L; Treré D; Derenzini M
    Cells; 2019 Jan; 8(1):. PubMed ID: 30650663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and ribosome biogenesis stress: the essentials.
    Golomb L; Volarevic S; Oren M
    FEBS Lett; 2014 Aug; 588(16):2571-9. PubMed ID: 24747423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ribosomes synthesis at the heart of cell proliferation].
    Madru C; Leulliot N; Lebaron S
    Med Sci (Paris); 2017; 33(6-7):613-619. PubMed ID: 28990563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential.
    Montanaro L; Treré D; Derenzini M
    Biochim Biophys Acta; 2012 Jan; 1825(1):101-10. PubMed ID: 22079382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.
    Scala F; Brighenti E; Govoni M; Imbrogno E; Fornari F; Treré D; Montanaro L; Derenzini M
    Oncogene; 2016 Feb; 35(8):977-89. PubMed ID: 25961931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolus, ribosomes, and cancer.
    Montanaro L; Treré D; Derenzini M
    Am J Pathol; 2008 Aug; 173(2):301-10. PubMed ID: 18583314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth control and ribosomopathies.
    Teng T; Thomas G; Mercer CA
    Curr Opin Genet Dev; 2013 Feb; 23(1):63-71. PubMed ID: 23490481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
    Bursac S; Brdovcak MC; Donati G; Volarevic S
    Biochim Biophys Acta; 2014 Jun; 1842(6):817-30. PubMed ID: 24514102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
    Brighenti E; Giannone FA; Fornari F; Onofrillo C; Govoni M; Montanaro L; Treré D; Derenzini M
    Oncotarget; 2016 Sep; 7(39):63226-63241. PubMed ID: 27557515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The negative regulation of ribosome biogenesis: a new Arf-dependent pathway controlling cell proliferation?].
    Ayrault O; Andrique L; Larsen CJ; Séité P
    Med Sci (Paris); 2006 May; 22(5):519-24. PubMed ID: 16687121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.
    Penzo M; Casoli L; Pollutri D; Sicuro L; Ceccarelli C; Santini D; Taffurelli M; Govoni M; Brina D; Trerè D; Montanaro L
    Int J Cancer; 2015 Mar; 136(5):E272-81. PubMed ID: 25273595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest.
    Kim HD; Kim TS; Kim J
    Oncogene; 2011 Jul; 30(30):3317-27. PubMed ID: 21383696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword.
    Hölzel M; Burger K; Mühl B; Orban M; Kellner M; Eick D
    Oncotarget; 2010 May; 1(1):43-47. PubMed ID: 21293052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.
    Chan JC; Hannan KM; Riddell K; Ng PY; Peck A; Lee RS; Hung S; Astle MV; Bywater M; Wall M; Poortinga G; Jastrzebski K; Sheppard KE; Hemmings BA; Hall MN; Johnstone RW; McArthur GA; Hannan RD; Pearson RB
    Sci Signal; 2011 Aug; 4(188):ra56. PubMed ID: 21878679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of p53 in ribosomopathies.
    Fumagalli S; Thomas G
    Semin Hematol; 2011 Apr; 48(2):97-105. PubMed ID: 21435506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the ribosome translate cancer?
    Ruggero D; Pandolfi PP
    Nat Rev Cancer; 2003 Mar; 3(3):179-92. PubMed ID: 12612653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics.
    Catez F; Dalla Venezia N; Marcel V; Zorbas C; Lafontaine DLJ; Diaz JJ
    Biochem Pharmacol; 2019 Jan; 159():74-81. PubMed ID: 30468711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.